Article | February 4, 2022

Considerations For Clinical Studies In Heavy Menstrual Bleeding

Source: Premier Research
Woman laptop telehealth remote iStock-1214389964

Heavy menstrual bleeding (HMB) is one of the most common gynecologic disorders among women of reproductive age, accounting for up to one-third of all gynecologic office visits HMB refers to bleeding associated with regular ovulatory cycles and involves blood loss greater than 80 ml per month. It is a subcategory of abnormal uterine bleeding (AUB), a broad term describing menstrual cycle irregularities involving frequency, regularity, duration, or volume of flow. The condition can adversely impact quality of life and can result in anemia.

In this blog post, explore key operational and methodological considerations for HMB clinical studies.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader